Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Abstract
It is generally thought that many drug molecules are transported across biological membranes via passive diffusion at a rate related to their lipophilicity. However, the types of biophysical forces involved in the interaction of drugs with lipid membranes are no different from those involved in their interaction with proteins, and so arguments based on lipophilicity could also be applied to drug uptake by membrane transporters or carriers. In this article, we discuss the evidence supporting the idea that rather than being an exception, carrier-mediated and active uptake of drugs may be more common than is usually assumed - including a summary of specific cases in which drugs are known to be taken up into cells via defined carriers - and consider the implications for drug discovery and development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Note that despite a widespread assumption that lipophilicity or log P is sufficient to account for drug distribution this is not in fact the case, as there are hundreds of natural transporters that drugs can use (e.g. [18,1714]).”
In the citing paper
“(Note that liophilicity per se may not be relevant, as drugs require carriers to cross membranes [18], and promiscuity and off-target effects increase with lipophilicity [1679].)”
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
CHEMIOSMOTIC COUPLING IN OXIDATIVE AND PHOTOSYNTHETIC PHOSPHORYLATION
MITCHELL, P. (1966) · Biological Reviews · doi:10.1111/j.1469-185x.1966.tb01501.x · Cited by 3,663
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Hucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg015 · Cited by 3,060
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512 · cited 1×
“, do not obey the Ro5 (for example, most antibacterial”
BackgroundThe influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403 · cited 1×
“This is because many of the recent trends in molecular drug design and development have been towards increased lipophilicity, leading to a greater likelihood of both a lack of selectivity and of attritio”
BackgroundThe Membrane Actions of Anesthetics and Tranquilizers
Seeman, P. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06931-5 · Cited by 2,246
Abraham, M. H. (1993) · Chemical Society Reviews · doi:10.1039/cs9932200073 · Cited by 1,968
Osmotic Stress Signaling and Osmoadaptation in Yeasts
Hohmann, S. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.2.300-372.2002 · Cited by 1,767
Research works printed but not linked: 1
- Jain, M. K. The Bimolecular Lipid Membrane. (Van Nostrand Reinhold, New York, 1972).
Cited by
Items 401–479 of 479
Miller, S. M., Moos, W. H., Munk, B. H., & Munk, S. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100625-2.00011-8 · Cited by 1
Déguénon, S. D. D. M., Hounmenou, C. G., Idohou, R., Tenté, B., Assogbadjo, A. E., & SINSIN, B. A. (2022) · Southern Forests a Journal of Forest Science · doi:10.2989/20702620.2022.2149365 · Cited by 1
Organ-on-chip models for pulmonary permeability studies
Lee, D., & Chambers, M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15510-9.00018-9 · Cited by 2
Lee, B. L., Kuczera, K., Lee, K., Childs, E. W., & Jas, G. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1827037 · Cited by 2
“It is suggested that the permeability across membrane lipid bilayer occurs most commonly by a passive diffusion process at a rate associated with the lipophilicity of the permeant (Dobson et al., 2009; Dobson & Kell, 2008; Giacomini et al., 2010; Hogben et al., 1959; H€ogerle & Winne, 1983).”
BackgroundGo with the flow — membrane transport in the gut
Thwaites, D. T. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.019 · Cited by 1
O’Hagan, S., Muelas, M. W., Day, P. J., Lundberg, E. K., & Kell, D. B. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/155697 · Cited by 1
Self-citationEvaluation of excipients for enhanced intestinal absorption of Rooibos flavonoids
Hlengwa, N. (2017) · Cited by 1
Li, J. J. (2020) · Wiley eBooks · doi:10.1002/9781119607311.ch3 · Cited by 2
Spatio-temporal Approach to Transport Dynamics in the Mammalian Ventricular System
Faubel, R. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4938 · Cited by 1
The enigma of flavonoids and bilitranslocase activity in the cardiovascular system
Žiberna, L., & Sabina, P. (2014) · ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)
Filppula, A. M. (2014) · Työväentutkimus Vuosikirja
Johnston, R. A. (2013) · The Sydney eScholarship Repository (The University of Sydney)
Prediction of Drug‐Likeness and its Integration into the Drug Discovery Process
Schuffenhauer, A., & Glick, M. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627448.ch2
Atkinson, M. (2013) · Wiley eBooks · doi:10.1002/9781118540343.ch2
Determination of Regulation of Drug‐Metabolizing Enzymes and Transporters
Zhang, B., & Xie, W. (2011) · Wiley eBooks · doi:10.1002/9781118067598.ch32
On the use of genomics to assess environmental risks of pharmaceuticals
Gunnarsson, L. M. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Analysis of Renal Transporters
Rüssel, F. G. M., & Masereeuw, R. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-8229-1_10
Drug transport and transporters
Bainton, R. J., & Kharasch, E. D. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781933.008
The importance of mathematics in systems biology
Kell, D. B. (2009) · Research Explorer (The University of Manchester)
Self-citationCell-penetrating peptides; chemical modification, mechanism of uptake and formulation development
Ezzat, K. (2012) · DiVA (Stockholm University)
Vildhede, A. M. (2015) · Uppsala University Publications (Uppsala University) · Cited by 1
Murabito, E., Colombo, R., Wu, C., Verma, M., Rehman, S., Snoep, J. L., Peng, S., Guan, N., Liao, X., & Westerhoff, H. V. (2015) · Quantitative Biology · doi:10.1007/s40484-015-0039-9
“There is abundant evidence in literature that the uptake of drugs is carrier-mediated rather than ‘ passive ’ [19 – 21].”
BackgroundDevelopmental Pharmacokinetics: Drug Disposition Relative to Age
Reed, M. D., & Bestic, M. L. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7436-5_2
Sprowl, J. A., & Sparreboom, A. (2014)
Yun, Y. E. (2013) · UWSpace (University of Waterloo)
Role of basolateral efflux transporters in intestinal absorption of drugs and prodrugs
Ming, X. (2008) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ckzf-bd14
Roshanbin, S. (2016) · DiVA (Digitala Vetenskapliga Arkivet)
Modelling Cellular Permeability via Carrier Mediated Transport
Sarupinda, T. I. (2016) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.17256 · Cited by 1
Prediction of Human Intestinal Absorption
Patel, R. (2017) · UA Campus Repository (The University of Arizona)
Li, J., Truong, J. K., Pachura, K. J., Rao, A., Gambeer, S., Fuchs, C. D., Karpen, S. J., Trauner, M. A., & Dawson, P. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.06.430841
Impact of Maternal Inflammatory Conditions on the Expression of Drug Transporters
Ghoneim, R. H. (2016) · TSpace (University of Toronto)
Bury, N. R. (2015) · Wiley eBooks · doi:10.1002/9781118394380.ch51
(2010) · CRC Press eBooks · doi:10.1201/b10292-9
Preformulation Considerations for Design of Oral Modified‐Release Products
Bergström, C. A. S., & Holm, R. (2022) · Wiley eBooks · doi:10.1002/9781119772729.ch5
Regional Intestinal Drug Absorption
Gonzalez-Alvarez, M. I., & Dahan, A. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-3657-6
Nies, A. T. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_3628
(2003) · CRC Press eBooks · doi:10.1201/9780203503935.ch5
Increasing Brain Exposure of Antibodies
Lesuisse, D. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_2
Balk, F., Hollender, J., & Schirmer, K. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4308054
Analysis of Human Gut Metabolites as Sources for the Design of Gut-Targeted DrugsPreprint
Gil-Pichardo, A., Sánchez-Ruiz, A., & Colmenarejo, G. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-2ndlx
Drug discovery: Standing on the shoulders of giants
Miller, S. M., Moos, W. H., Munk, B. H., Munk, S. A., Hart, C. P., & Spellmeyer, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824304-6.00001-8
Determination of Regulation of Drug Metabolizing Enzymes and Transporters
Chai, S. C., Chen, T., & Xie, W. (2023) · Wiley eBooks · doi:10.1002/9781119660699.ch41
Lindley, D. J., Carl, S. M., Herrera‐Ruiz, D., Pan, L. F., Ward, L. B., Goole, J., Gudmundsson, O. S., Behymer, M. M., & Knipp, G. T. (2023) · Wiley eBooks · doi:10.1002/9781119660699.ch20
Biological and Physiological Features of the Gastrointestinal Tract Relevant to Oral Drug Absorption
Ho, P. C. (2023) · Wiley eBooks · doi:10.1002/9781119660699.ch4
Cabrera‐Pérez, M. Á., Bermejo-Sanz, M., González‐Álvarez, M., González‐Álvarez, I., Lara, V. V., & Chou, W.-H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15510-9.00017-7
Andiga, L. G. E., Bekono, B. D., Mama, D. B., Amoa, P. P., Owono, L. C. O., & Meva’à, L. M. (2024) · Computational Molecular Bioscience · doi:10.4236/cmb.2024.142003
Dey, D., Marciano, S., Poryvai, A., Groborz, O., Wohlrábová, L., Slanina, T., & Schreiber, G. (2024) · eLife · doi:10.7554/elife.97255.1
Anwar, H., Mukhtar, I., Muzaffar, H., Irfan, S., Saleem, S., & Ijaz, F. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_2 · Cited by 1
Dey, D., Marciano, S., Poryvai, A., Groborz, O., Wohlrábová, L., Slanina, T., & Schreiber, G. (2024) · eLife · doi:10.7554/elife.97255.2
Pantazis, J. C., Pomeroy, A. E., & Palmer, A. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.08.681217
“Solute carrier (SLC) and ATP-binding cassette (ABC) transporters are key determinants of cellular uptake and efflux, especially for drugs that structurally resemble endogenous metabolites 53,54 .”
EFFECT OF THE CELL POLARIZATION ON ENDOCYTIC PROPERTIES OF THE HUMAN BRAIN ENDOTHELIAL CELLS
Partti, S. (2014) · Helda - University of Helsinki Institutional Repository
Gil-Pichardo, A., Sánchez-Ruiz, A., & Colmenarejo, G. (2024) · Figshare · doi:10.6084/m9.figshare.26626693
Luo, H., Lu, L., Liu, N., Li, Q., Yang, X., & Zhang, Z. (2021) · Figshare · doi:10.6084/m9.figshare.15071237
Biyomalzemelerle Sinyal Yolu Modülasyonu: Hücresel Mekanizmalardan Terapötik Uygulamalara
Çırçırlı, B., & Emre, M. C. (2025) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub1126.c4580
Metabolic Reprogramming in Cancer Stem Cells
Ranjan, G., Dasgupta, S., Mishra, U. K., Sunita, P., & Pattanayak, S. P. (2026) · Cancer treatment and research · doi:10.1007/978-3-032-21861-2_8
Chakraborty, A., Gupta, P. D., Meier, A., Roy, A., & Pullanchery, S. (2026) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6c03977
Oyeneyin, O. E., Ibrahim, A., & Gumede, N. J. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100602
Drug Delivery With Metal–Organic Frameworks
Tarabay, N. W., Evtushenko, A. S., Kiapi, M. R. A., Chen, X., Caamaño, K., Fruk, L., & Fairen‐Jiménez, D. (2026) · Angewandte Chemie Novit · doi:10.1002/anov.70037
Lysosomal Exocytosis and Drug Resistance in K562 Cells
Mlejnek, P., & Doležel, P. (2026) · Scientia Pharmaceutica · doi:10.3390/scipharm94040088
Wang, Y., Masood, H., & Nomikou, N. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70340
“This phase is likely to be dominated by passive diffusion and ABCG2-mediated efflux [31–34].”
BindingDB Entry 50004779: Rational approaches to improving selectivity in drug design.
BindingDB (2020) · UC San Diego · doi:10.7270/q2d79f84
BindingDB Entry 50019550: Basic Nitrogen (BaN) Is a Key Property of Antimalarial Chemical Space.
BindingDB (2024) · UC San Diego · doi:10.7270/q2p84h8w
Metadata
- Authors
- Dobson, P. D., & Kell, D. B.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Kell, Douglas B.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-03
- Volume
- 7
- Issue
- 3
- Pages
- 205-220
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2157619122
- Cited by
- 475
- References
- 265
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 20 · 2023: 19 · 2022: 18 · 2021: 24 · 2020: 27 · 2019: 20 · 2018: 17 · 2017: 28 · 2016: 36 · 2015: 43 · 2014: 42 · 2013: 29 · 2012: 36
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- Royal Society
- Wolfson Foundation
- Engineering and Physical Sciences Research Council
- Biotechnology and Biological Sciences Research Council (747/1, BB/D007)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- passive diffusion, lipophilicity, membrane transporters, drug discovery, drug development
- MeSH terms
- Animals, Biological Transport, Cell Membrane, Cell Membrane Permeability, Pharmaceutical Preparations, Humans, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.